Why read this report if you work in the space sector?
Hear directly what the pharmaceutical sector needs from microgravity research, the evidence required to unlock demand, and the infrastructure challenges that must be solved to enable commercial adoption.
- This report provides a direct view of what pharmaceutical companies would need to see before committing time, expertise, data or funding to microgravity R&D.
- It identifies the evidence, infrastructure and operational requirements that matter most to end users, including reproducibility, sample return, cold-chain logistics and development timelines.
- It highlights where the strongest commercial opportunities may emerge and provides a roadmap for aligning space capabilities with real pharmaceutical demand.
Download the report
|
